Skip to main content
. 2022 Sep 17;17(3):318–328. doi: 10.1093/ecco-jcc/jjac139

Table 3.

Rates of endoscopic and clinical recurrence.

Low-risk patients High-risk patients
Prophylactic n = 11 Endoscopy-guided n = 44 p-value Prophylactic n = 37 Endoscopy-guided n = 111 p-value
Endoscopic recurrence, n [%] 4 [36.4] 18 [40.9] 0.78 9 [24.3] 49 [44.5] 0.03
Modified Rutgeerts score, n [%] 0.36 0.23
i0 2 [18.2] 12 [27.3] 12 [32.4] 21 [19.1]
i1 3 [27.3] 6 [13.6] 4 [10.8] 15 [13.6]
i2a 2 [18.2] 8 [18.2] 12[32.4] 25 [22.7]
i2b 1 [9.1] 12 [27.3] 6 [16.2] 27 [24.5]
i3 - 2 [4.5] 1 [2.7] 12 [10.9]
i4 3 [27.3] 4 [9.4] 2 [5.4] 10 [9.1]
Clinical recurrence, n [%]
1 year 3 [27.3] 13 [29.5] 0.73 9 [24.3] 34 [30.6] 0.19
2 years 5 [45.4] 16 [36.4] 0.22 14 [37.8] 46 [41.4] 0.19
3 years 5 [45.4] 19 [43.2] 0.94 20 [54.1] 54 [48.6] 0.43

Values in bold are significant.